Literature DB >> 17363078

Short-term regulation of tyrosine hydroxylase activity and expression by endothelin-1 and endothelin-3 in the rat posterior hypothalamus.

Guadalupe Perfume1, Carolina Morgazo, Sabrina Nabhen, Agustina Batistone, Sandra I Hope, Liliana G Bianciotti, Marcelo S Vatta.   

Abstract

Brain catecholamines are involved in several biological functions regulated by the hypothalamus. We have previously reported that endothelin-1 and -3 (ET-1 and ET-3) modulate norepinephrine release in the anterior and posterior hypothalamus. As tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine biosynthesis, the aim of the present work was to investigate the effects of ET-1 and ET-3 on TH activity, total enzyme level and the phosphorylated forms of TH in the rat posterior hypothalamus. Results showed that ET-1 and ET-3 diminished TH activity but the response was abolished by both selective ET(A) and ET(B) antagonists (BQ-610 and BQ-788, respectively). In addition ET(A) and ET(B) selective agonists (sarafotoxin S6b and IRL-1620, respectively) failed to affect TH activity. In order to investigate the intracellular signaling coupled to endothelins (ETs) response, nitric oxide (NO), phosphoinositide, cAMP/PKA and CaMK-II pathways were studied. Results showed that N(omega)-nitro-l-arginine methyl ester and 7-nitroindazole (NO synthase and neuronal NO synthase inhibitors, respectively), 1H-[1,2,4]-oxadiazolo[4,3-alpha]quinozalin-1-one and KT-5823 (soluble guanylyl cyclase, and PKG inhibitors, respectively) inhibited ETs effect on TH activity. Further, sodium nitroprusside and 8-bromoguanosine-3',5'-cyclic monophosphate (NO donor and cGMP analog, respectively) mimicked ETs response. ETs-induced reduction of TH activity was not affected by a PKA inhibitor but it was abolished by PLC, PKC and CaMK-II inhibitors as well as by an IP(3) receptor antagonist. On the other hand, both ETs did not modify TH total level but reduced the phosphorylation of serine residues of the enzyme at positions 19, 31 and 40. Present results suggest that ET-1 and ET-3 diminished TH activity through an atypical ET or ET(C) receptor coupled to the NO/cGMP/PKG, phosphoinositide and CaMK-II pathways. Furthermore, TH diminished activity may result from the reduction of the phosphorylated sites of the enzyme without changes in its total level. Taken jointly present and previous results support that ET-1 and ET-3 may play a relevant role in the modulation of catecholaminergic neurotransmission in the posterior hypothalamus of the rat.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363078     DOI: 10.1016/j.regpep.2007.01.011

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  4 in total

1.  Short-term effects of endothelins on tyrosine hydroxylase activity and expression in the olfactory bulb of normotensive rats.

Authors:  Sabrina L Nabhen; Guadalupe Perfume; María A Battistone; Andrés Rossi; Tamara Abramoff; Liliana G Bianciotti; Marcelo S Vatta
Journal:  Neurochem Res       Date:  2008-10-11       Impact factor: 3.996

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Novel enhancement mechanism of tyrosine hydroxylase enzymatic activity by nitric oxide through S-nitrosylation.

Authors:  Yuanyuan Wang; Chun Chau Sung; Kenny K K Chung
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

4.  SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.

Authors:  Lei L Chen; Jing Zhu; Jonathan Schumacher; Chongjuan Wei; Latha Ramdas; Victor G Prieto; Arnie Jimenez; Marco A Velasco; Sheryl R Tripp; Robert H I Andtbacka; Launce Gouw; George M Rodgers; Liansheng Zhang; Benjamin K Chan; Pamela B Cassidy; Robert S Benjamin; Sancy A Leachman; Marsha L Frazier
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.